Live search
TopFind is fetching the latest matches for your search.
We reviewed 75 live results for infliximab infusion and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Medicine and Rheumatology.
Source: Samitivej Hospital
Description
A biologic DMARD (TNF inhibitor) administered as an intravenous infusion (100 mg sterile powder). This service is typically provided in a hospital setting for patients with rheumatoid arthritis requiring intensive biologic therapy.
Best for
intravenous infusion therapy, biologic DMARD treatment, TNF inhibitor access and hospital-based medical care
Rating
Source: Hospital Kuala Lumpur
Description
Clinical administration of Truxima (rituximab biosimilar) for the treatment of hematological cancers and autoimmune disorders, provided within a supervised hospital setting with specialized oncology support.
Best for
Public healthcare patients, Hematological malignancy treatment, Supervised IV infusion and Oncology care in Kuala Lumpur
Rating
Source: Takeda
Description
Kiovig is a 10% solution (100 mg/mL) of human normal immunoglobulin (IVIg) for intravenous or subcutaneous administration. It is used as replacement therapy for patients with primary immunodeficiency (PID) and secondary immunodeficiency (SID). Additionally, it acts as an immunomodulatory therapy for conditions such as immune thrombocytopenic purpura (ITP), Guillain-Barré syndrome, Kawasaki disease, Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), and Multifocal Motor Neuropathy (MMN). The product is available in various vial sizes, including 1g, 2.5g, 5g, 10g, 20g, and 30g concentrations.
Best for
primary immunodeficiency replacement, CIDP and MMN treatment, Kawasaki disease management, intravenous immunoglobulin therapy and subcutaneous infusion preference
Rating
| Compare | Infliximab Infusion | Truxima Intravenous Infusion Administration | Kiovig 100mg/mL Solution for Infusion |
|---|---|---|---|
| Source | Samitivej Hospital | Hospital Kuala Lumpur | Takeda |
| Description | A biologic DMARD (TNF inhibitor) administered as an intravenous infusion (100 mg sterile powder). This service is typically provided in a hospital setting for patients with rheumatoid arthritis requiring intensive biologic therapy. | Clinical administration of Truxima (rituximab biosimilar) for the treatment of hematological cancers and autoimmune disorders, provided within a supervised hospital setting with specialized oncology support. | Kiovig is a 10% solution (100 mg/mL) of human normal immunoglobulin (IVIg) for intravenous or subcutaneous administration. It is used as replacement therapy for patients with primary immunodeficiency (PID) and secondary immunodeficiency (SID). Additionally, it acts as an immunomodulatory therapy for conditions such as immune thrombocytopenic purpura (ITP), Guillain-Barré syndrome, Kawasaki disease, Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), and Multifocal Motor Neuropathy (MMN). The product is available in various vial sizes, including 1g, 2.5g, 5g, 10g, 20g, and 30g concentrations. |
| Best for | intravenous infusion therapy, biologic DMARD treatment, TNF inhibitor access and hospital-based medical care | Public healthcare patients, Hematological malignancy treatment, Supervised IV infusion and Oncology care in Kuala Lumpur | primary immunodeficiency replacement, CIDP and MMN treatment, Kawasaki disease management, intravenous immunoglobulin therapy and subcutaneous infusion preference |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
If you want the most balanced option to start with, I recommend:
"Infliximab Infusion from Samitivej Hospital."
I picked this because Ideal for patients requiring hospital-monitored biologic infusion therapy for rheumatoid arthritis management.